Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Geriatrics
Published in: BMC Geriatrics 1/2023

Open Access 01-12-2023 | Sarcopenia | Research

Prevalence and risk factors of osteosarcopenia: a systematic review and meta-analysis

Authors: Tianjin Huang, Chen Li, Faxiu Chen, Dunan Xie, Chuhua Yang, Yuting Chen, Jintao Wang, Jiming Li, Fei Zheng

Published in: BMC Geriatrics | Issue 1/2023

Login to get access

Abstract

Background

Osteosarcopenia is a syndrome with a concomitant presence of both sarcopenia and osteopenia/osteoporosis. It increases the risk of frailty, falls, fractures, hospitalization, and death. Not only does it burden the lives of older adults, but it also increases the economic burden on health systems around the world. This study aimed to review the prevalence and risk factors of osteosarcopenia to generate important references for clinical work in this area.

Methods

Pubmed, Embase, Cochrane Library, Web of Science, CNKI, Wanfang, CBM, and VIP databases were searched from inception until April 24th, 2022. The quality of studies included in the review was evaluated using the NOS and AHRQ Scale. Pooled effects of the prevalence and associated factors were calculated using random or fixed effects models. Egger’s test, Begg’s test, and funnel plots were used to test the publication bias. Sensitivity analysis and subgroup analysis were conducted to identify the sources of heterogeneity. Statistical analysis was performed using Stata 14.0 and Review Manager 5.4.

Results

A total of 31 studies involving 15,062 patients were included in this meta-analysis. The prevalence of osteosarcopenia ranged from 1.5 to 65.7%, with an overall prevalence of 21% (95% CI: 0.16–0.26). The risk factors for osteosarcopenia were female (OR 5.10, 95% CI: 2.37–10.98), older age (OR 1.12, 95% CI: 1.03–1.21), and fracture (OR 2.92, 95% CI: 1.62–5.25).

Conclusion

The prevalence of osteosarcopenia was high. Females, advanced age, and history of fracture were independently associated with osteosarcopenia. It is necessary to adopt integrated multidisciplinary management.
Appendix
Available only for authorised users
Literature
1.
Hirschfeld HP, Kinsella R, Duque G. Osteosarcopenia: where bone, muscle, and fat collide. Osteoporos Int. 2017;28(10):2781–90.PubMedCrossRef
2.
Huo YR, Suriyaarachchi P, Gomez F, Curcio CL, Boersma D, Gunawardene P, Demontiero O, Duque G. Phenotype of sarcopenic obesity in older individuals with a history of falling. Arch Gerontol Geriatr. 2016;65:255–9.PubMedCrossRef
3.
Yoo JI, Ha YC, Kwon HB, Lee YK, Koo KH, Yoo MJ. High prevalence of Sarcopenia in korean patients after hip fracture: a case-control study. J KOREAN MED SCI. 2016;31(9):1479–84.PubMedPubMedCentralCrossRef
4.
Scott D, Seibel M, Cumming R, Naganathan V, Blyth F, Le Couteur DG, Handelsman DJ, Waite LM, Hirani V. Does combined Osteopenia/Osteoporosis and Sarcopenia Confer Greater Risk of Falls and Fracture Than either Condition alone in older men? The Concord Health and Ageing in Men Project. J Gerontol A Biol Sci Med Sci. 2019;74(6):827–34.PubMedCrossRef
5.
Bauer JM, Cruz-Jentoft AJ, Fielding RA, Kanis JA, Reginster JY, Bruyere O, Cesari M, Chapurlat R, Al-Daghri N, Dennison E, et al. Is there enough evidence for osteosarcopenic obesity as a distinct entity? A critical literature review. Calcif Tissue Int. 2019;105(2):109–24.PubMedCrossRef
6.
Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994;4(6):368–81.PubMedCrossRef
7.
Cao L, Morley JE. Sarcopenia is recognized as an Independent Condition by an international classification of Disease, Tenth Revision, clinical modification (ICD-10-CM) code. J AM MED DIR ASSOC. 2016;17(8):675–7.PubMedCrossRef
8.
Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, Cederholm T, Coats AJ, Cummings SR, Evans WJ, et al. Sarcopenia with limited mobility: an international consensus. J AM MED DIR ASSOC. 2011;12(6):403–9.PubMedPubMedCentralCrossRef
9.
Rosenberg IH. Epidemiologic and methodologic problems in determining nutritional status of older persons. Proceedings of a conference. Albuquerque, New Mexico, October 19–21, 1988. AM J CLIN NUTR. 1989;50(5 Suppl):1121–235.
10.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, et al. Sarcopenia: european consensus on definition and diagnosis: report of the european Working Group on Sarcopenia in Older People. AGE AGEING. 2010;39(4):412–23.PubMedPubMedCentralCrossRef
11.
Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, Abellan VKG, Andrieu S, Bauer J, Breuille D, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J AM MED DIR ASSOC. 2011;12(4):249–56.PubMedCrossRef
12.
Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, Chou MY, Chen LY, Hsu PS, Krairit O, et al. Sarcopenia in Asia: consensus report of the asian Working Group for Sarcopenia. J AM MED DIR ASSOC. 2014;15(2):95–101.PubMedCrossRef
13.
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, et al. Sarcopenia: revised european consensus on definition and diagnosis. AGE AGEING. 2019;48(1):16–31.PubMedCrossRef
14.
Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia diagnosis and treatment. J AM MED DIR ASSOC. 2020;21(3):300–7.PubMedCrossRef
15.
Avin KG, Bloomfield SA, Gross TS, Warden SJ. Biomechanical Aspects of the muscle-bone Interaction. CURR OSTEOPOROS REP; 2015.
16.
Frost HM. Bone’s mechanostat: a 2003 update. Anat Rec A Discov Mol Cell Evol Biol. 2003;275(2):1081–101.PubMedCrossRef
17.
Bettis T, Kim BJ, Hamrick MW. Impact of muscle atrophy on bone metabolism and bone strength: implications for muscle-bone crosstalk with aging and disuse. Osteoporos Int. 2018;29(8):1713–20.PubMedPubMedCentralCrossRef
18.
19.
Kirk B, Al SA, Duque G, Osteosarcopenia. A case of geroscience. Aging Med (Milton). 2019;2(3):147–56.PubMedCrossRef
20.
Delphine M, Katharina J, Nuria LC. Muscle–bone crosstalk: Emerging Opportunities for Novel Therapeutic Approaches to treat Musculoskeletal Pathologies. Biomedicines. 2017;5(4):62.CrossRef
21.
Hamrick MW. A role for myokines in muscle-bone interactions. Exerc Sport Sci Reviews. 2011;39(1):43.CrossRef
22.
Meric CC, Whitson HE, Berry SD, Fielding RA, Troen BR. AGS and NIA Bench-to Bedside Conference Summary: Osteoporosis and Soft Tissue (Muscle and Fat) Disorders. J AM GERIATR SOC. 2020;68(4).
23.
Saedi AA, Hassan EB, Duque G. The diagnostic role of fat in osteosarcopenia. 2019.
24.
Teng Z, Zhu Y, Teng Y, Long Q, Hao Q, Yu X, Yang L, Lv Y, Liu J, Zeng Y, et al. The analysis of osteosarcopenia as a risk factor for fractures, mortality, and falls. Osteoporos Int. 2021;32(11):2173–83.PubMedCrossRef
25.
Salech F, Marquez C, Lera L, Angel B, Saguez R, Albala C. Osteosarcopenia predicts Falls, Fractures, and mortality in chilean Community-Dwelling older adults. J AM MED DIR ASSOC. 2021;22(4):853–8.PubMedCrossRef
26.
27.
Inoue T, Maeda K, Nagano A, Shimizu A, Ueshima J, Murotani K, Sato K, Hotta K, Morishita S, Tsubaki A. Related factors and clinical outcomes of Osteosarcopenia: a narrative review. NUTRIENTS. 2021;13(2).
28.
Polito A, Barnaba L, Ciarapica D, Azzini E. Osteosarcopenia: a narrative review on Clinical Studies. INT J MOL SCI. 2022;23(10).
29.
Barnsley J, Buckland G, Chan PE, Ong A, Ramos AS, Baxter M, Laskou F, Dennison EM, Cooper C, Patel HP. Pathophysiology and treatment of osteoporosis: challenges for clinical practice in older people. AGING CLIN EXP RES. 2021;33(4SI):759–73.PubMedPubMedCentralCrossRef
30.
Nielsen BR, Abdulla J, Andersen HE, Schwarz P, Suetta C. Sarcopenia and osteoporosis in older people: a systematic review and meta-analysis. EUR GERIATR MED. 2018;9(4):419–34.PubMedCrossRef
31.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.PubMedPubMedCentralCrossRef
32.
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. EUR J EPIDEMIOL. 2010;25(9):603–5.PubMedCrossRef
33.
Pourhassan M, Buehring B, Stervbo U, Rahmann S, Mölder F, Rütten S, Trampisch U, Babel N, Westhoff TH, Wirth R. Osteosarcopenia, an asymmetrical overlap of two connected Syndromes: data from the OsteoSys Study. NUTRIENTS. 2021;13(11).
34.
Kobayashi K, Imagama S, Ando K, Machino M, Ota K, Tanaka S, Morozumi M, Kanbara S, Ito S, Ishiguro N, et al. Epidemiology and effect on physical function of osteosarcopenia in community-dwelling elderly people in Japan. MOD RHEUMATOL. 2020;30(3):592–7.PubMedCrossRef
35.
Fahimfar N, Zahedi TF, Gharibzadeh S, Shafiee G, Tanha K, Heshmat R, Nabipour I, Raeisi A, Jalili A, Larijani B, et al. Prevalence of Osteosarcopenia and its Association with Cardiovascular Risk factors in iranian older people: Bushehr Elderly Health (BEH) Program. Calcif Tissue Int. 2020;106(4):364–70.PubMedCrossRef
36.
Nielsen BR, Andersen HE, Haddock B, Hovind P, Schwarz P, Suetta C. Prevalence of muscle dysfunction concomitant with osteoporosis in a home-dwelling danish population aged 65–93 years - the Copenhagen Sarcopenia Study. EXP GERONTOL. 2020;138:110974.PubMedCrossRef
37.
Reiss J, Iglseder B, Alzner R, Mayr-Pirker B, Pirich C, Kässmann H, Kreutzer M, Dovjak P, Reiter R. Sarcopenia and osteoporosis are interrelated in geriatric inpatients. Z GERONTOL GERIATR. 2019;52(7):688–93.PubMedPubMedCentralCrossRef
38.
Drey M, Sieber CC, Bertsch T, Bauer JM, Schmidmaier R. Osteosarcopenia is more than sarcopenia and osteopenia alone. AGING CLIN EXP RES. 2016;28(5):895–9.PubMedCrossRef
39.
Huo YR, Suriyaarachchi P, Gomez F, Curcio CL, Boersma D, Muir SW, Montero-Odasso M, Gunawardene P, Demontiero O, Duque G. Phenotype of osteosarcopenia in older individuals with a history of falling. J AM MED DIR ASSOC. 2015;16(4):290–5.PubMedCrossRef
40.
Okamura H, Ishikawa K, Kudo Y, Matsuoka A, Maruyama H, Emori H, Yamamura R, Hayakawa C, Tani S, Tsuchiya K, et al. Risk factors predicting osteosarcopenia in postmenopausal women with osteoporosis: a retrospective study. PLoS ONE. 2020;15(8):e237454.CrossRef
41.
Yoo JI, Kim H, Ha YC, Kwon HB, Koo KH. Osteosarcopenia in patients with hip fracture is related with high mortality. J KOREAN MED SCI. 2018;33(4):e27.PubMedCrossRef
42.
Saeki C, Oikawa T, Kanai T, Nakano M, Torisu Y, Sasaki N, Abo M, Saruta M, Tsubota A. Relationship between osteoporosis, sarcopenia, vertebral fracture, and osteosarcopenia in patients with primary biliary cholangitis. Eur J Gastroenterol Hepatol. 2021;33(5):731–7.PubMedCrossRef
43.
Inoue T, Maeda K, Satake S, Matsui Y, Arai H. Osteosarcopenia, the co-existence of osteoporosis and sarcopenia, is associated with social frailty in older adults. AGING CLIN EXP RES. 2022;34(3):535–43.PubMedCrossRef
44.
Pang BWJ, Wee SL, Chen KK, Lau LK, Jabbar KA, Seah WT, Ng DHM, Tan QLL, Jagadish MU, Ng TP. Coexistence of osteoporosis, sarcopenia and obesity in community-dwelling adults – the Yishun Study. Osteoporos Sarcopenia. 2021;7(1):17–23.PubMedPubMedCentralCrossRef
45.
Bani Hassan E, Vogrin S, Hernandez Viña I, Boersma D, Suriyaarachchi P, Duque G. Hemoglobin levels are low in sarcopenic and osteosarcopenic older persons. CALCIFIED TISSUE INT. 2020;107(2):135–42.CrossRef
46.
Kirk B, Phu S, Brennan-Olsen SL, Bani Hassan E, Duque G. Associations between osteoporosis, the severity of sarcopenia and fragility fractures in community-dwelling older adults. EUR GERIATR MED. 2020;11(3):443–50.PubMedCrossRef
47.
Intriago M, Maldonado G, Guerrero R, Messina OD, Rios C. Bone Mass Loss and Sarcopenia in Ecuadorian Patients. Journal of Aging Research. 2020;2020.
48.
Wang YJ, Wang Y, Zhan JK, Tang ZY, He JY, Tan P, Deng HQ, Huang W, Liu YS. Sarco-osteoporosis: Prevalence and association with frailty in Chinese community-dwelling older adults. INT J ENDOCRINOL. 2015;2015.
49.
Hamad B, Basaran S, Coskun Benlidayi I. Osteosarcopenia among postmenopausal women and handgrip strength as a practical method for predicting the risk. AGING CLIN EXP RES. 2020;32(10):1923–30.PubMedCrossRef
50.
Saeki C, Takano K, Oikawa T, Aoki Y, Kanai T, Takakura K, Nakano M, Torisu Y, Sasaki N, Abo M et al. Comparative assessment of sarcopenia using the JSH, AWGS, and EWGSOP2 criteria and the relationship between sarcopenia, osteoporosis, and osteosarcopenia in patients with liver cirrhosis. BMC MUSCULOSKEL DIS. 2019;20(1).
51.
Saeki C, Kanai T, Nakano M, Oikawa T, Torisu Y, Abo M, Saruta M, Tsubota A. Relationship between osteosarcopenia and frailty in patients with chronic liver disease. J CLIN MED. 2020;9(8):1–12.CrossRef
52.
Lin YH, Shih YT, Teng MMH. The impact of the “osteo” component of osteosarcopenia on fragility fractures in post-menopausal women. INT J MOL SCI. 2021;22(10).
53.
Lopez-Teros MT, Rosas-Carrasco O, Sanchez-Garcia S, Castro-Porras L, Luna-Lopez A, Agudelo-Botero M. The Association of Osteosarcopenia with Functional Disability in Community-Dwelling mexican adults 50 and older. Volume 8. FRONTIERS IN MEDICINE; 2021.
54.
Chew J, Yeo A, Yew S, Tan CN, Lim JP, Hafizah Ismail N, Lim WS. Nutrition mediates the relationship between Osteosarcopenia and Frailty: a pathway analysis. NUTRIENTS. 2020;12(10).
55.
Sepulveda-Loyola W, Phu S, Hassan EB, Brennan-Olsen SL, Zanker J, Vogrin S, Conzade R, Kirk B, Al Saedi A, Probst V, et al. The joint occurrence of osteoporosis and Sarcopenia (Osteosarcopenia): definitions and characteristics. J AM MED DIR ASSOC. 2020;21(2):220–5.PubMedCrossRef
56.
Okayama A, Nakayama N, Kashiwa K, Horinouchi Y, Fukusaki H, Nakamura H, Katayama S. Prevalence of Sarcopenia and Its Association with Quality of Life, Postural Stability, and Past Incidence of Falls in Postmenopausal Women with Osteoporosis: A Cross-Sectional Study. Healthcare (Basel, Switzerland). 2022;10(2).
57.
Mathieu M, Guillot P, Riaudel T, Boureau A, Chapelet G, Brouessard C, de Decker L, Berrut G. Association between Bone Mineral density and Fat Mass Independent of lean Mass and physical activity in women aged 75 or older. NUTRIENTS. 2021;13(6).
58.
Di Monaco M, Castiglioni C, Bardesono F, Milano E, Massazza G. Sarcopenia, osteoporosis and the burden of prevalent vertebral fractures: a cross-sectional study of 350 women with hip fracture. EUR J PHYS REHAB MED. 2020;56(2):184–90.
59.
Suriyaarachchi P, Gomez F, Curcio CL, Boersma D, Murthy L, Grill V, Duque G. High parathyroid hormone levels are associated with osteosarcopenia in older individuals with a history of falling. MATURITAS. 2018;113:21–5.PubMedCrossRef
60.
Buehring B, Krueger D, Binkley N. Effect of including historical height and radius BMD measurement on sarco-osteoporosis prevalence. J CACHEXIA SARCOPENI. 2013;4(1):47–54.CrossRef
61.
Pechmann LM, Petterle RR, Moreira CA, Borba VZC. Osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitus. ARCH ENDOCRIN METAB. 2021;65(6):801–10.
62.
Hassan EB, Duque G, Osteosarcopenia. A new geriatric syndrome. AUST FAM PHYSICIAN. 2017;46(11):849–53.PubMed
63.
Kaji H. Interaction between muscle and bone. J Bone Metabolism. 2014;21(1):29–40.CrossRef
64.
Kirk B, Zanker J, Duque G. Osteosarcopenia: epidemiology, diagnosis, and treatment—facts and numbers. J Cachexia Sarcopenia Muscle. 2020;11(3):609–18.PubMedPubMedCentralCrossRef
65.
Dent E, Morley JE, Cruz-Jentoft AJ, Arai H, Kritchevsky SB, Guralnik J, Bauer JM, Pahor M, Clark BC, Cesari M, et al. International Clinical Practice Guidelines for Sarcopenia (ICFSR): screening, diagnosis and management. J NUTR HEALTH AGING. 2018;22(10):1148–61.PubMedCrossRef
66.
Bunchorntavakul C. Sarcopenia and Frailty in cirrhosis: Assessment and Management. Med Clin North Am. 2023;107(3):589–604.PubMedCrossRef
67.
de Sire A, Lippi L, Aprile V, Calafiore D, Folli A, D’Abrosca F, Moalli S, Lucchi M, Ammendolia A, Invernizzi M. Pharmacological, nutritional, and rehabilitative interventions to improve the Complex management of osteoporosis in patients with chronic obstructive Pulmonary Disease: a narrative review. J Pers Med. 2022;12(10).
68.
Malmstrom TK, Morley JE. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J AM MED DIR ASSOC. 2013;14(8):531–2.PubMedCrossRef
69.
Beaudart C, McCloskey E, Bruyere O, Cesari M, Rolland Y, Rizzoli R, de Carvalho IA, Thiyagarajan JA, Bautmans I, Bertiere M et al. Sarcopenia in daily practice: assessment and management. BMC GERIATR. 2016;16.
70.
Kanis JA, Harvey NC, Johansson H, Oden A, Leslie WD, McCloskey EV. FRAX and fracture prediction without bone mineral density. CLIMACTERIC. 2015;18(Suppl 2):2–9.PubMedCrossRef
71.
Guigoz Y, Vellas B, Garry PJ. Assessing the nutritional status of the elderly: the Mini Nutritional Assessment as part of the geriatric evaluation. NUTR REV. 1996;54(1 Pt 2):59–S65.
72.
Kirk B, Miller S, Zanker J, Duque G. A clinical guide to the pathophysiology, diagnosis and treatment of osteosarcopenia. MATURITAS. 2020;140:27–33.PubMedCrossRef
73.
Zanker J, Duque G. Osteoporosis in older persons: Old and New Players. J AM GERIATR SOC. 2019;67(4):831–40.PubMedCrossRef
74.
Liu W, Chen S, Jiang F, Zhou C, Tang S. Malnutrition and physical frailty among nursing home residents: a cross-sectional study in China. J NUTR HEALTH AGING. 2020;24(5):500–6.PubMedCrossRef
75.
Chen Z, Li WY, Ho M, Chau PH. The prevalence of Sarcopenia in Chinese older adults: Meta-Analysis and Meta-Regression. NUTRIENTS. 2021;13(5).
76.
Papadopoulou SK, Tsintavis P, Potsaki P, Papandreou D. Differences in the prevalence of Sarcopenia in Community-Dwelling, nursing home and hospitalized individuals. A systematic review and Meta-analysis. J NUTR HEALTH AGING. 2020;24(1):83–90.PubMedCrossRef
77.
78.
Kacimi R, Long CS, Karliner JS. Chronic hypoxia modulates the interleukin-1beta-stimulated inducible nitric oxide synthase pathway in cardiac myocytes. Circulation. 1997;96(6):1937–43.PubMedCrossRef
79.
Di Monaco M, Vallero F, Di Monaco R, Tappero R. Prevalence of sarcopenia and its association with osteoporosis in 313 older women following a hip fracture. Arch Gerontol Geriatr. 2011;52(1):71–4.PubMedCrossRef
80.
Walsh MC, Hunter GR, Livingstone MB. Sarcopenia in premenopausal and postmenopausal women with osteopenia, osteoporosis and normal bone mineral density. Osteoporos Int. 2006;17(1):61–7.PubMedCrossRef
81.
Ceglia L, Harris SS. Vitamin D and its role in skeletal muscle. Calcif Tissue Int. 2013;92(2):151–62.PubMedCrossRef
82.
Keller K, Engelhardt M. Strength and muscle mass loss with aging process. Age and strength loss. Muscles Ligaments Tendons J. 2013;3(4):346–50.PubMedCrossRef
83.
Oleksik AM, Ewing S, Shen W, van Schoor NM, Lips P. Impact of incident vertebral fractures on health related quality of life (HRQOL) in postmenopausal women with prevalent vertebral fractures. Osteoporos Int. 2005;16(8):861–70.PubMedCrossRef
84.
JafariNasabian P, Inglis JE, Kelly OJ, Ilich JZ. Osteosarcopenic obesity in women: impact, prevalence, and management challenges. Int J Womens Health. 2017;9:33–42.PubMedPubMedCentralCrossRef
85.
Ormsbee MJ, Prado CM, Ilich JZ, Purcell S, Siervo M, Folsom A, Panton L. Osteosarcopenic obesity: the role of bone, muscle, and fat on health. J Cachexia Sarcopenia Muscle. 2014;5(3):183–92.PubMedPubMedCentralCrossRef
Metadata
Title
Prevalence and risk factors of osteosarcopenia: a systematic review and meta-analysis
Authors
Tianjin Huang
Chen Li
Faxiu Chen
Dunan Xie
Chuhua Yang
Yuting Chen
Jintao Wang
Jiming Li
Fei Zheng
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2023
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-023-04085-9

Other articles of this Issue 1/2023

BMC Geriatrics 1/2023 Go to the issue

Case report

IgG4-related eosinophilic pleural effusion: a case report

Research

Translation, cross-cultural adaption, validity and reliability of a composite physical function scale for adults aged 65 + years in a Danish context

Research

An ensemble machine learning approach to predict postoperative mortality in older patients undergoing emergency surgery

Study protocol

Digital assistance systems in the field of incontinence care for individuals in need of long-term care (EASY): study protocol of a stratified randomised controlled trial

Research

Associations of multilingualism and language proficiency with cognitive functioning: epidemiological evidence from the SwissDEM study in community dwelling older adults and long-term care residents

Research

Knowledge, attitude, behaviour, and influencing factors of home-based medication safety among community-dwelling older adults with chronic diseases: a cross-sectional study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits